News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,332 Results
Type
Article (5359)
Company Profile (11)
Press Release (98962)
Multimedia
Podcasts (9)
Webinars (4)
Section
Business (30423)
Career Advice (781)
Deals (7335)
Drug Delivery (10)
Drug Development (14344)
Employer Resources (57)
FDA (2319)
Job Trends (2765)
News (54477)
Policy (4723)
Tag
Academia (276)
Accelerated approval (2)
Adcomms (2)
Allergies (18)
Alliances (6826)
ALS (21)
Alzheimer's disease (215)
Antibody-drug conjugate (ADC) (26)
Approvals (2324)
Artificial intelligence (37)
Autoimmune disease (3)
Bankruptcy (74)
Best Places to Work (2398)
BIOSECURE Act (1)
Biosimilars (22)
Biotechnology (13)
Bladder cancer (12)
Brain cancer (5)
Breast cancer (41)
Cancer (379)
Cardiovascular disease (25)
Career advice (623)
Career pathing (2)
CAR-T (16)
Cell therapy (51)
Cervical cancer (3)
Clinical research (12114)
Collaboration (101)
Compensation (40)
Complete response letters (3)
COVID-19 (340)
CRISPR (5)
C-suite (30)
Cystic fibrosis (30)
Data (427)
Denatured (3)
Depression (12)
Diabetes (39)
Diagnostics (911)
Digital health (4)
Diversity, equity & inclusion (11)
Drug discovery (21)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (17)
Earnings (13441)
Editorial (8)
Employer branding (4)
Employer resources (46)
Events (12572)
Executive appointments (147)
FDA (2603)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (98)
Gene editing (14)
Generative AI (6)
Gene therapy (56)
GLP-1 (126)
Government (551)
Grass and pollen (1)
Guidances (49)
Healthcare (3192)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (22)
Indications (9)
Infectious disease (352)
Inflammatory bowel disease (30)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (23)
Interviews (120)
IPO (3626)
IRA (6)
Job creations (458)
Job search strategy (551)
Labor market (6)
Layoffs (58)
Leadership (2)
Legal (1002)
Liver cancer (11)
Lung cancer (41)
Lymphoma (19)
Machine learning (1)
Management (25)
Manufacturing (33)
MASH (19)
Medical device (2096)
Medtech (2097)
Mergers & acquisitions (3889)
Metabolic disorders (114)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (12)
Neuropsychiatric disorders (5)
Neuroscience (306)
NextGen: Class of 2025 (1229)
Non-profit (502)
Now hiring (3)
Obesity (52)
Opinion (68)
Ovarian cancer (29)
Pain (18)
Pancreatic cancer (25)
Parkinson's disease (11)
Partnered (4)
Patents (50)
Patient recruitment (15)
Peanut (12)
People (9047)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (3779)
Phase II (5509)
Phase III (4068)
Pipeline (323)
Policy (17)
Postmarket research (309)
Preclinical (1322)
Press Release (6)
Prostate cancer (21)
Psychedelics (3)
Radiopharmaceuticals (28)
Rare diseases (75)
Real estate (650)
Recruiting (21)
Regulatory (3513)
Reports (10)
Research institute (294)
Resumes & cover letters (153)
Rett syndrome (3)
RNA editing (1)
RSV (3)
Schizophrenia (20)
Series A (15)
Series B (9)
Service/supplier (2)
Sickle cell disease (6)
Special edition (6)
Spinal muscular atrophy (15)
Sponsored (4)
Startups (424)
Supply chain (10)
Tariffs (5)
The Weekly (5)
Vaccines (67)
Venture capitalists (7)
Weight loss (27)
Women's health (4)
Worklife (5)
Date
Last 7 days (185)
Last 30 days (509)
Last 365 days (5849)
2025 (2068)
2024 (6560)
2023 (7430)
2022 (10493)
2021 (10710)
2020 (9622)
2019 (7725)
2018 (5861)
2017 (5326)
2016 (4513)
2015 (5482)
2014 (3804)
2013 (2708)
2012 (3074)
2011 (3269)
2010 (2730)
Location
Africa (160)
Alabama (10)
Alaska (2)
Arizona (27)
Arkansas (1)
Asia (5207)
Australia (673)
California (1061)
Canada (265)
China (76)
Colorado (58)
Connecticut (30)
Delaware (43)
Europe (11525)
Florida (301)
Georgia (30)
Idaho (5)
Illinois (111)
India (2)
Indiana (34)
Iowa (3)
Japan (22)
Kansas (17)
Kentucky (2)
Louisiana (5)
Maine (22)
Maryland (191)
Massachusetts (831)
Michigan (14)
Minnesota (47)
Missouri (15)
Montana (1)
Nebraska (3)
Nevada (10)
New Hampshire (8)
New Jersey (473)
New Mexico (3)
New York (324)
North Carolina (208)
Northern California (438)
Ohio (26)
Oregon (2)
Pennsylvania (222)
Puerto Rico (7)
Rhode Island (3)
South America (200)
South Carolina (14)
South Dakota (1)
Southern California (402)
Tennessee (6)
Texas (264)
United States (4438)
Utah (37)
Virginia (30)
Washington D.C. (18)
Washington State (121)
Wisconsin (1)
104,332 Results for "fort worth lap band".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XTL Names Mr. Noam Band as its New Chief Executive Officer
April 8, 2025
·
3 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
Press Releases
Diabetes Care Market Size to worth to Reach USD 62.73 Billion by 2032, Coherent Market Insights
May 8, 2025
·
1 min read
Collaboration
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M
Merck has not disclosed which of its peptide therapies it plans to develop oral formulations for.
April 15, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Lilly Throws Sangamo a Lifeline With Pact Worth Potential $1.4B+
Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in preclinical studies has shown the ability to cross the blood-brain barrier.
April 4, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Paratek Broadens Portfolio With OptiNose Buy Worth up to $330M
Paratek Pharmaceuticals is betting that OptiNose’s chronic rhinosinusitis treatment will be a partner to its antibiotic treatment Nuzyra.
March 20, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Scopolamine Market size to worth USD 797.4 Mn by 2032, says Coherent Market Insights
April 14, 2025
·
1 min read
Press Releases
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
October 21, 2024
·
13 min read
Press Releases
Preeclampsia Diagnostics Market size to worth USD 4.60 Billion by 2032, says Coherent Market Insights
April 9, 2025
·
1 min read
1 of 10,434
Next
